For the first time in history, we have access to the science within each of us, and it can tell us so much about ourselves and how to make the best choices for our body and overall well-being. DNA, our genetic code, is the starting point. From there, we layer on all the life choices we make in terms of foods we eat, products we use, the environment we live in, etc. It’s the combination of our genetics and our life choices that make up the biology of our body. This biology is unique to each of us… we call it U-ology. Here at Viazoi, we use our scientific and medical expertise to create personalized programs that are based on your biology. From DNA testing to molecular microbe analysis, we use your U-ology to tailor a wellness program that is just for you.
Viazoi provides state-of-the-art wellness tests. All of our tests are based on submitting your sample from your own home (no lab visits, no appointments). Samples are then analyzed, recommendations made and sent directly to you electronically.
Results and recommendations you can trust
Tests are run using clinical grade instrumentation and protocols at a CLIA licensed laboratory. All recommendations are backed by industry experts.
We keep test results confidential in full compliance with HIPPA and only collect information that is needed to provide you with a high-quality experience.
Meet the TEAM
Areg Boyamyan, MBA
Areg Boyamyan has held management positions in Aerospace and Diagnostics/Life Sciences industries for more than two decades. As Senior Vice President and Head of Foundation Laboratory since 2005, Boyamyan has lead Foundation Laboratory to becoming one of the largest privately-held clinical laboratories in the West Coast. Through the development and growth of a workforce of more than 400 dedicated individuals and 100 plus patient service centers, Boyamyan has successfully positioned Foundation Laboratory in the industry as a state of the art clinical laboratory, delivering world-class services to thousands of users.
His vision continues to steer the company as an innovative leader with the introduction of Viazoi, a division of Foundation Laboratory offering specialized testing worldwide.
Boyamyan possesses BS in physics and an MBA in management.
Evangeline Gonzalez, MBA
Evangeline Gonzalez has more than 22 years of commercialization experience within the Diagnostics and Life Science industry and has successfully led Market Development and Product Development for a wide array of global businesses ranging from Next Generation DNA Sequencing, protein analysis, and other Molecular Biology technologies.
Gonzalez joins Viazoi from Beckman Coulter Diagnostics, a $3.4 billion dollar company where she was most recently Senior VP of Global Marketing, responsible for facilitating growth and global market development strategy.
She began her career at Pharmacia Biotech as a research associate developing products for protein separation. She worked in R&D, Product Marketing and Strategic Markel & Business Development, holding various assignments of increasing responsibility at Genentech, Life Technologies, and Advanced Cell Diagnostics.
Gonzalez has a BS in chemistry and biochemistry and an MBA in entrepreneurship from San Francisco State University.
Zareh C Baghoomian, DDS
Zareh Baghoomian has over 18 years of direct clinical, operational, and purchasing experience in the healthcare industry. Since joining Foundation Laboratory in 2011, he has implemented multiple efficiency standards driving down costs and helping to bring high-quality tests to patients who would not otherwise be able to afford them.
Dr. Baghoomian initially began his career in healthcare as a dentist catering to poor and disabled patients in the inner cities of Los Angeles. There he realized that in order to have the most impact on the community, he needed to stretch every resource to the limit and to optimize every step of the way. This mantra has continued to be a beacon in his approach to the challenges facing diagnostic laboratories today.
Dr. Baghoomian earned a Bachelor of Science in Gerontology and a DDS from the University of Southern California.
Arineh Vartanian, MPH
Arineh Vartanian, MPH, has over ten years of experience in healthcare, including product and marketing development and management, healthcare advocacy and health and bio analytics.
Before joining Viazoi in 2016, Arineh was with Zynx Health, a subsidiary of Hearst Corporation, as a Product and Content Developer and Account Manager. While there, she managed a digital healthcare system client portfolio valued at ~ $24MM. Prior to that, she was at the University of Southern California, where she directed studies on current public health issues with academic industry leaders.
Arineh began her career at The Scripps Research Institute in San Diego, where she conducted and managed research in virus-immune system interactions and viral pathogenesis, pertaining to conditions including the measles and prion disease. Her work has been published in many reputable healthcare journals. Arineh has a degree in Biology and a minor in geographic specialization in Eurasian studies from the University of California in San Diego. She also received her Masters in Public Health, with a focus on Epidemiology and Biostatistics, from the University of Southern California in 2010.
Frieda Jordan CLS, CHS, PhD, ESHI (hon.)
Dr. Frieda Jordan is the co-founder and president of the Armenian Bone Marrow Donor Registry (ABMDR), which was established in 1999 to bring the hope of life-saving bone marrow stem cell transplantation to thousands afflicted by blood-related illnesses.
After earning a PhD in biochemistry from Kings College London University, Dr. Jordan headed the Laboratory Services of the Anthony Nolan Research Center at the Royal Free Hospital in London. Subsequently, she was appointed Associate Director of the HLA and Immunogenetics Laboratory at Cedars-Sinai Medical Center, in Los Angeles. Since 2000, she has headed the DNA Molecular Typing Division at Foundation Laboratory, also in Los Angeles.
Dr. Jordan has conducted workshops worldwide and co-authored numerous medical papers. She is a member of the British, European, and American Societies of Histocompatibility and Immunogenetics, as well as the World Marrow Donor Association and NMDP. Dr. Jordan has been appointed as an official EFI accreditation inspector. She has carried out inspections in Italy, Turkey, Cyprus, and Colombia.
Dr. Jordan’s work as a researcher and president of ABMDR has earned her many accolades in the fields of science, medicine, technology, and humanitarian service. She is the recipient of, among others, the 28th Congressional District Woman of the Year Award, conferred on her by US Congressman Adam Schiff , the Ruby and Service awards from Soroptimist International, the YMCA Women of Heart and Excellence Award, the Outstanding Woman in Business Award in the fields of Science and Technology from US Senator Jack Scott as well as California Assembly members Dario Frommer and Carol Liu, and Armenia’s Presidential Award in the fields of Science and Medicine, St. Nerses the Graceful Medal.
Reza Massoumi CLS, Dr.Sc.
52 years experience in clinical laboratory operations. 21 years laboratory owner/partner, CEO of two different laboratories from startup turned into multimillion-dollar businesses (1971-1992). Owner/partner and President of a startup turned into a very successful laboratory reagent and kit manufacturing company (1972-1984). Clinical laboratory consultant helping two startup clinical laboratories and two failing laboratories to thriving businesses.
BS Microbiology, California State University Los Angeles, MS Medical Technology Tehran University, Doctor of Science PWU.
Meet the ADVISORY BOARD
Richard S. Creager, PhD
Richard has more than 30 years’ experience in the in vitro diagnostics (IVD) industry. Currently, Dr. Creager is a partner in IOI Partners, a management consulting firm for IVD and biotechnology companies. Previously, Richard was SVP for Molecular Diagnostics and Chief Science Officer for Beckman Coulter from 2011 – 2016. He also served as Group Vice President for Beckman Coulter’s Immunoassay Business and led the growth of that business from ~ $40m to more than $700m (1997 – 2011). During his tenure, he was instrumental in identifying acquiring several key technologies and companies. He also successfully launched several innovative biomarkers that helped drive the growth of the company.
Dr. Creager also held senior executive positions with Kallestad Diagnostics Sanofi Diagnostics Pasteur, the latter at which he led the development of that company’s first automated immunoassay analyzer. Richard was the chairman of the board of directors for Medical Alley, a 501(c)3 non-profit trade association that enables health technology and care organizations to innovate, succeed, and influence the evolution of healthcare in Minnesota and the surrounding region. Formerly he served as an editorial board member for In Vitro Diagnostics Technology/Dx.
He currently serves on the board of two non-profits:  [email protected], which serves to strengthen STEM education in Orange County middle schools and  1for2 education foundation, whose mission is to build a community of scholars, dedicated to being life-long learners and are committed to “pay-it-forward.” He also serves on the board of OnRamp Bioinformatics. Richard has a B.S. from Muhlenberg College, a M.S. from Duquesne University, and a PhD from the University of Pittsburgh School of Medicine. He also attended The Wharton School of Business for their Advanced Management Program.
Shamiram R. Feinglass, MD, MPH
Shamiram R. Feinglass, MD, MPH leads Global Medical, Government, Reimbursement, and Clinical Affairs for Life Sciences and Diagnostics at Danaher Corporation and drives talent diversity in every environment in which she works or leads. Often working with global leaders and regulators, Dr. Feinglass was formerly the Vice President for Global Medical and Regulatory Affairs at Zimmer, Inc., where she was responsible for global leadership in the development of strategy and execution of all corporate programs in Clinical Affairs, Market Access, Regulatory Affairs and Policy. Dr. Feinglass has served as a Medical Officer at the Centers for Medicare and Medicaid Services in the Coverage and Analysis Group, and as a Commander with the U.S. Public Health Service. Well published, Dr. Feinglass has also been clinical faculty at several health sciences universities.
A U.S. federal affairs policy professional before she was a physician, Dr. Feinglass is a native of San Francisco and a graduate of Smith College. She earned her Doctor of Medicine and Master of Public Health from the Emory Schools of Medicine and Public Health. She completed an Internal Medicine Residency at Oregon Health Sciences University, a Preventive Medicine Residency at Emory School of Medicine, the Robert Wood Johnson Clinical Scholars Program at the University of Washington, and is Board Certified in Preventive Medicine. Dr. Feinglass is a Fellow of the third class of the Aspen Health Innovators Fellowship Program and a member of the Aspen Global Leadership Network.
A sought-after speaker and expert in international medical device and diagnostics policy, Dr. Feinglass has served on a variety of panels and advisory boards for the FDA, FasterCures, The Brookings Institute, Pew Charitable Trusts, Oxford University, and international registry groups. A mother of two, she is currently a BMX state champion and was a member of the USA BMX 2017 World Championship Team.
Steve C de Baca
Steve has an extensive twenty plus year background in the medical device and invitro diagnostic device industry and has been with Beckman Coulter (BEC) Diagnostics since July 2013 as the SVP QRA. He soon thereafter expanded to take on the full responsibilities for the QRA organization for the Danaher Diagnostic Platform supporting BEC, Cepheid, Leica Biosystems (LBS) and Radiometer Medical (RAD). Prior to this role, Steve was the Vice President of Quality for the $6B Cardiology Rhythm and Vascular (CRV) and Neuromodulation division of Boston Scientific Corporation, a position he has held since 2010.
He was with Boston Scientific since 2005, serving in a variety of capacities and with responsibility for locations around the globe. Prior to Boston Scientific, Steve was with Biosense Webster, Inc., a Johnson and Johnson Company, REVA Medical, and Quidel among others.
Steve has a BS in Engineering and Industrial Technology and an MBA from California State University, Long Beach. In addition, from 2006 to 2013, Steve was the lead instructor for the Masters of Regulatory Affairs program for quality system and regulatory compliance at St. Cloud State University in Minnesota.